Obeticholic Acid is a synthetic derivative of chenodeoxycholic acid, a naturally occurring bile acid. Its molecular formula is C26H44O4 and the structure features modifications at the steroidal core that enhance its activity and selectivity. The compound usually comes as a white or off-white powder, solid at room temperature, and sometimes can appear in the form of crystalline flakes or pearls, depending on the manufacturing process. People working with Obeticholic Acid will notice its distinct, slightly bitter taste and a subtle odor, common to bile acid derivatives. The density stands at about 1.2 g/cm³, providing a clue to its material handling and storage requirements.
One of the key things about Obeticholic Acid is its solubility profile. It dissolves in organic solvents such as ethanol and dimethyl sulfoxide, with limited solubility in water. This characteristic guides formulation in pharmaceuticals, requiring specialized solvents or carriers. In powder form, it flows reasonably well, but storing the material in a dry, cool environment is crucial to prevent clumping or degradation. Some batches appear as fine crystals, while others are compressed into flakes—manufacturers usually select the physical form based on the needs of downstream users.
The melting point typically falls between 165°C and 175°C, an important detail when designing industrial processes or storage systems. Anyone handling the compound should wear appropriate protective equipment because, though not classed as highly hazardous, obeticholic acid dusts can irritate eyes, skin, and the respiratory tract. It makes sense to have a dedicated storage cabinet, away from direct sunlight, heat sources, and moisture.
Looking closely at the molecular makeup, the steroidal backbone and functional groups of Obeticholic Acid drive its biological properties. This specificity gives the compound its main value in medical therapies, particularly for chronic liver diseases. The HS Code for export and customs purposes falls under 2937.29, which covers bile acid derivatives. As used in pharmaceutical synthesis, the raw material should reach a purity of at least 98%, and reputable suppliers document every lot with certificates of analysis—including reference spectra and impurity profiles.
Not only does high purity support safety, it also assures users that assay values, density, and crystalline properties remain within a tight typical range. Impurities or changes in physical form can impact product consistency, especially in scaled processes. Suppliers often provide Obeticholic Acid as both research-grade and GMP-grade material, catering to the needs of laboratories, manufacturers, and clinics.
Obeticholic Acid acts as a raw material for advanced liver disease medications. Researchers in the pharmaceutical industry use the acid to study cellular pathways and develop new treatments. Because its effects are significant, trace exposure through the environment or workplace can affect health, particularly over prolonged periods. Proper waste management and spill containment procedures cut down the risk of water or soil contamination. Safety data sheets provide valuable guidance on accidental contact, ingestion, or inhalation. While not classified as acutely toxic under global chemical regulations, a careful, organized approach to transportation and storage remains essential.
People have realistic concerns about the costs and risks of using specialty chemicals like Obeticholic Acid. Rigorous training, regular monitoring, and strict documentation help organizations manage these issues. Maintaining tightly controlled processes—such as closed-system powder handling and fume extraction—has a direct impact on safety outcomes. The industry’s shift to more sustainable, accountable practices could mean sourcing greener solvents, improving packaging, and supporting take-back or recycling programs for leftover chemicals and containers. These steps not only protect workers and communities, they build trust in the supply chain.
Sound management of Obeticholic Acid—starting from raw material sourcing through safe handling, storage, and disposal—can support public health and innovation in drug development. It falls to manufacturers, researchers, logistics teams, and regulators to take an active role, sharing clear and honest information about chemical properties, hazards, and available solutions. Stakeholders armed with good science and practical experience spot trouble early and turn lessons learned into stronger policies and protective measures. Attention to detail on the ground always beats lofty promises: well-packed drums, up-to-date inventory, and well-maintained safety gear spell the difference between costly mistakes and reliable operations.